Speaker(s): 

Charles Brightbill, MS, CIP, CIM, Director, IRB Operations & HRPP, Geisinger - has nothing to disclose.

Moderator(s): 

Brenda Cook, MHSA, Research Compliance Analyst, Geisinger - has nothing to disclose. 

Learning Objectives: 

At the conclusion of this session, the participant should be able to: 

  • Discuss the ethical functions of informed consent.
  • Outline the regulatory requirements for informed consent.
  • Identify different consent processes.
  • Understand the application of a waiver or alteration of consent.
  • Describe the requirements for parental permission, assent, and surrogate consent.
  • List investigator responsibilities.
  • Provide resources to improve informed consent.

Disclosure of Relevant Financial Relationships with/without Commercial Interests:

The Planning Committee consisting of Brenda Cook, MHSA, David Carey, PhD, Christin Spatz, MD, Lori Biacchi, Rebecca Stoudt, DNP, PhD, CRNA, Candice Laubach, MBA, and Sonia Lobo, PhD have no identified disclosures. 

CE Committee Member/Content Reviewers have nothing to disclose. 

Any/All relevant financial relationships have been mitigated. 

Content Disclosure: 

This presentation/content is HIPAA compliant. 

Commercial Support for this Session

None

Session date: 
04/14/2025 - 4:00pm to 5:00pm EDT
Location: 
Virtual via Microsoft Teams
Danville, PA 17822
United States
  • 1.00 AMA PRA Category 1 Credit
  • 1.00 ANCC
  • 1.00 Participation Credit
Please login or register to take this course.